Chapter 274 |
2017 -- H 6322 Enacted 07/21/2017 |
A N A C T |
RELATING TO INSURANCE - ACCIDENT AND SICKNESS INSURANCE POLICIES |
Introduced By: Representatives Ackerman, Carson, Marshall, Craven, and Fogarty |
Date Introduced: June 09, 2017 |
It is enacted by the General Assembly as follows: |
SECTION 1. Section 27-18-50 of the General Laws in Chapter 27-18 entitled "Accident |
and Sickness Insurance Policies" is hereby amended to read as follows: |
27-18-50. Drug coverage. [Effective January 1, 2017.] |
(a) Any accident and sickness insurer that utilizes a formulary of medications for which |
coverage is provided under an individual or group-plan, master contract shall require any |
physician or other person authorized by the department of health to prescribe medication to |
prescribe from the formulary. A physician or other person authorized by the department of health |
to prescribe medication shall be allowed to prescribe medications previously on, or not on, the |
accident and sickness insurer's formulary if he or she believes that the prescription of the non- |
formulary medication is medically necessary. An accident and sickness insurer shall be required |
to provide coverage for a non-formulary medication only when the non-formulary medication |
meets the accident and sickness insurer's medical-exception criteria for the coverage of that |
medication. |
(b) An accident and sickness insurer's medical exception criteria for the coverage of non- |
formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
(c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
section may appeal the denial in accordance with the rules and regulations promulgated by the |
department of health pursuant to chapter 17.12 of title 23. |
(d) Prior to removing a prescription drug from its plan's formulary or making any change |
in the preferred or tiered, cost-sharing status of a covered prescription drug, an accident and |
sickness insurer must provide at least thirty (30) days' notice to authorized prescribers by |
established communication methods of policy and program updates and by updating available |
references on web-based publications. All adversely affected members must be provided at least |
thirty (30) days' notice prior to the date such change becomes effective by a direct notification: |
(i) The written or electronic notice must contain the following information: |
(A) The name of the affected prescription drug; |
(B) Whether the plan is removing the prescription drug from the formulary, or changing |
its preferred or tiered, cost-sharing status; and |
(C) The means by which subscribers may obtain a coverage determination or medical |
exception, in the case of drugs that will require prior authorization or are formulary exclusions |
respectively. |
(ii) An accident and sickness insurer may immediately remove from its plan formularies |
covered prescription drugs deemed unsafe by the accident and sickness insurer or the Food and |
Drug Administration, or removed from the market by their manufacturer, without meeting the |
requirements of this section. |
(e) This section shall not apply to insurance coverage providing benefits for: (1) |
hHospital confinement indemnity; (2) dDisability income; (3) aAccident only; (4) lLong-term |
care; (5) Medicare supplement; (6) lLimited-benefit health; (7) sSpecified-disease indemnity; (8) |
sSickness or bodily injury or death by accident or both; or (9) oOther limited-benefit policies. |
SECTION 2. Section 27-19-42 of the General Laws in Chapter 27-19 entitled "Nonprofit |
Hospital Service Corporations" is hereby amended to read as follows: |
27-19-42. Drug coverage. [Effective January 1, 2017.] |
(a) Any nonprofit, hospital-service corporation that utilizes a formulary of medications |
for which coverage is provided under an individual or group-plan, master contract shall require |
any physician or other person authorized by the department of health to prescribe medication to |
prescribe from the formulary. A physician or other person authorized by the department of health |
to prescribe medication shall be allowed to prescribe medications previously on, or not on, the |
nonprofit, hospital-service corporation's formulary if he or she believes that the prescription of |
the non-formulary medication is medically necessary. A nonprofit, hospital-service corporation |
shall be required to provide coverage for a non-formulary medication only when the non- |
formulary medication meets the nonprofit, hospital-service corporation's medical-exception |
criteria for the coverage of that medication. |
(b) A nonprofit, hospital-service corporation's medical-exception criteria for the coverage |
of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
(c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
section may appeal the denial in accordance with the rules and regulations promulgated by the |
department of health pursuant to chapter 17.12 of title 23. |
(d) Prior to removing a prescription drug from its plan's formulary or making any change |
in the preferred or tiered cost-sharing status of a covered prescription drug, a nonprofit, hospital- |
service corporation must provide at least thirty (30) days' notice to authorized prescribers by |
established communication methods of policy and program updates and by updating available |
references on web-based publications. All adversely affected members must be provided at least |
thirty (30) days' notice prior to the date such change becomes effective by a direct notification: |
(i) The written or electronic notice must contain the following information: |
(A) The name of the affected prescription drug; |
(B) Whether the plan is removing the prescription drug from the formulary, or changing |
its preferred or tiered, cost-sharing status; and |
(C) The means by which subscribers may obtain a coverage determination or medical |
exception, in the case of drugs that will require prior authorization or are formulary exclusions |
respectively. |
(ii) A nonprofit, hospital-service corporation may immediately remove from its plan |
formularies covered prescription drugs deemed unsafe by the nonprofit, hospital-service |
corporation or the Food and Drug Administration, or removed from the market by their |
manufacturer, without meeting the requirements of this section. |
SECTION 3. Section 27-20-37 of the General Laws in Chapter 27-20 entitled "Nonprofit |
Medical Service Corporations" is hereby amended to read as follows: |
27-20-37. Drug coverage. [Effective January 1, 2017.] |
(a) Any nonprofit, medical-service corporation that utilizes a formulary of medications |
for which coverage is provided under an individual or group-plan, master contract shall require |
any physician or other person authorized by the department of health to prescribe medication to |
prescribe from the formulary. A physician or other person authorized by the department of health |
to prescribe medication shall be allowed to prescribe medications previously on, or not on, the |
nonprofit, medical-service corporation's formulary if he or she believes that the prescription of |
the non-formulary medication is medically necessary. A nonprofit, hospital medical-service |
corporation shall be required to provide coverage for a non-formulary medication only when the |
non-formulary medication meets the nonprofit, medical-service corporation's medical-exception |
criteria for the coverage of that medication. |
(b) A nonprofit, medical-service corporation's medical-exception criteria for the coverage |
of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
(c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
section may appeal the denial in accordance with the rules and regulations promulgated by the |
department of health pursuant to chapter 17.12 of title 23. |
(d) Prior to removing a prescription drug from its plan's formulary or making any change |
in the preferred or tiered, cost-sharing status of a covered prescription drug, a nonprofit, medical- |
service corporation must provide at least thirty (30) days' notice to authorized prescribers by |
established communication methods of policy and program updates and by updating available |
references on web-based publications. All adversely affected members must be provided at least |
thirty (30) days' notice prior to the date such change becomes effective by a direct notification: |
(i) The written or electronic notice must contain the following information: |
(A) The name of the affected prescription drug; |
(B) Whether the plan is removing the prescription drug from the formulary, or changing |
its preferred or tiered, cost-sharing status; and |
(C) The means by which subscribers may obtain a coverage determination or medical |
exception, in the case of drugs that will require prior authorization or are formulary exclusions |
respectively. |
(ii) A nonprofit, medical-service corporation may immediately remove from its plan |
formularies covered prescription drugs deemed unsafe by the nonprofit, medical-service |
corporation or the Food and Drug Administration, or removed from the market by their |
manufacturer, without meeting the requirements of this section. |
SECTION 4. Section 27-20.1-15 of the General Laws in Chapter 27-20.1 entitled |
"Nonprofit Dental Service Corporations" is hereby amended to read as follows: |
27-20.1-15. Drug coverage. [Effective January 1, 2017.] |
(a) Any nonprofit, dental-service corporation that utilizes a formulary of medications for |
which coverage is provided under an individual or group-plan, master contract shall require any |
physician or other person authorized by the department of health to prescribe medication to |
prescribe from the formulary. A physician or other person authorized by the department of health |
to prescribe medication shall be allowed to prescribe medications previously on, or not on, the |
nonprofit, dental-service corporation's formulary if he or she believes that the prescription of the |
non-formulary medication is medically necessary. A nonprofit, dental-service corporation shall be |
required to provide coverage for a non-formulary medication only when the non-formulary |
medication meets the nonprofit, dental-service corporation's medical-exception criteria for the |
coverage of that medication. |
(b) A nonprofit, dental-service corporation's medical-exception criteria for the coverage |
of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
(c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
section may appeal the denial in accordance with the rules and regulations promulgated by the |
department of health pursuant to chapter 17.12 of title 23. |
(d) Prior to removing a prescription drug from its plan's formulary or making any change |
in the preferred or tiered, cost-sharing status of a covered prescription drug, a nonprofit, dental- |
service corporation must provide at least thirty (30) days' notice to authorized prescribers by |
established communication methods of policy and program updates and by updating available |
references on web-based publications. All adversely affected members must be provided at least |
thirty (30) days' notice prior to the date such change becomes effective by a direct notification: |
(i) The written or electronic notice must contain the following information: |
(A) The name of the affected prescription drug; |
(B) Whether the plan is removing the prescription drug from the formulary, or changing |
its preferred or tiered, cost-sharing status; and |
(C) The means by which subscribers may obtain a coverage determination or medical |
exception, in the case of drugs that will require prior authorization or are formulary exclusions |
respectively. |
(ii) A nonprofit, dental-service corporation may immediately remove from its plan |
formularies covered prescription drugs deemed unsafe by the nonprofit, dental-service |
corporation or the Food and Drug Administration, or removed from the market by their |
manufacturer, without meeting the requirements of this section. |
SECTION 5. Section 27-41-51 of the General Laws in Chapter 27-41 entitled "Health |
Maintenance Organizations" is hereby amended to read as follows: |
27-41-51. Drug coverage. [Effective January 1, 2017.] |
(a) Any health-maintenance organization that utilizes a formulary of medications for |
which coverage is provided under an individual or group-plan, master contract shall require any |
physician or other person authorized by the department of health to prescribe medication to |
prescribe from the formulary. A physician or other person authorized by the department of health |
to prescribe medication shall be allowed to prescribe medications previously on, or not on, the |
health-maintenance organization's formulary if he or she believes that the prescription of non- |
formulary medication is medically necessary. A health-maintenance organization shall be |
required to provide coverage for a non-formulary medication only when the non-formulary |
medication meets the health-maintenance organization's medical-exception criteria for the |
coverage of that medication. |
(b) A health-maintenance organization's medical-exception criteria for the coverage of |
non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
(c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
section may appeal the denial in accordance with the rules and regulations promulgated by the |
department of health pursuant to chapter 17.12 of title 23. |
(d) Prior to removing a prescription drug from its plan's formulary or making any change |
in the preferred or tiered, cost-sharing status of a covered prescription drug, a health-maintenance |
organization must provide at least thirty (30) days' notice to authorized prescribers by established |
communication methods of policy and program updates and by updating available references on |
web-based publications. All adversely affected members must be provided at least thirty (30) |
days' notice prior to the date such change becomes effective by a direct notification: |
(i) The written or electronic notice must contain the following information: |
(A) The name of the affected prescription drug; |
(B) Whether the plan is removing the prescription drug from the formulary, or changing |
its preferred or tiered, cost-sharing status; and |
(C) The means by which subscribers may obtain a coverage determination or medical |
exception, in the case of drugs that will require prior authorization or are formulary exclusions |
respectively. |
(ii) A health-maintenance organization may immediately remove from its plan |
formularies covered prescription drugs deemed unsafe by the health-maintenance organization or |
the Food and Drug Administration, or removed from the market by their manufacturer, without |
meeting the requirements of this section. |
SECTION 6. This act shall take effect upon passage. |
======== |
LC002866 |
======== |